How dependent is India on HPV Vaccine Bulk imports?

India imports $0.14 bn, mostly from Belgium. Its Critical Manufacturing Dependency Index is 63.46/100 (High), with a localisation potential of 58.

HPV Vaccine Bulk

High dependencyBuild-nowPharmaceuticals & APIsReasoned estimateHS 3002.20

$0.14 bnAnnual import

30%Indian capability

4,908Supplier concentration (HHI)

₹2,424 crTo localise

Why India imports it. Reasoned estimate: India has limited domestic capacity for hpv vaccine bulk; sector trade patterns indicate continued import reliance.

Why it matters. Strategic dependency within pharma value chain; affects downstream manufacturing competitiveness.

Can India localise it? Partial

Where it comes from. Belgium (58%), China (30%), USA (12%).

Scorecard

The ten indices

CMDI 63.46Dependency

LPI 58Localisation potential

IAI 66.25Investment attractiveness

SRI 67.58Supply risk

SCI 51.5Supply-chain complexity

TRI 43.75Technology readiness

IMI 66.5Industrial multiplier

NSRI 57.25National-security relevance

EPI 65.25Export potential

ICGI 58.36Capability gap

Intelligence

Related signals

Sources

Primary references

pharmaceuticals.gov.in ↗

Confidence: Reasoned estimate. Reasoned estimate derived from sector trade patterns and HS code classification; specific company/number values are modelled. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).